Grand Pharmaceutical Group Limited (00512)

AuditorFromToRelease Date / Document LinksReason for Change
Deloitte25-Nov-26
HLB Hodgson Impey Cheng19-Feb-1325-Nov-26In light of the Group's overseas expansion strategy, the Board decided to rotate its external auditor. Appointing a larger-scale external auditor with more extensive international networks (Deloitte) will enhance audit efficiency and coverage, better meet future development needs, and maintain independence and objectivity. Deloitte also provides a more comprehensive scope of financial reporting work, more ample staffing, and more robust support for overseas operations compared to HLB.
ShineWing (Hong Kong)28-Nov-0613-Dec-12
Historical transition (details not available in archive)
BDO (HK)30-Mar-0618-Oct-06
Historical transition (details not available in archive)
BDO (HK)23-Sept-0415-Mar-06
Historical transition (details not available in archive)
Moores Rowland17-Mar-0326-Aug-04
Historical transition (details not available in archive)
PwC (HK)23-Jul-0214-Mar-03
Historical transition (details not available in archive)
Arthur Andersen07-Dec-9523-Jul-02
Historical transition (details not available in archive)